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The ability to map regional brain activity by monitor ing changes in hemodynamics using functional magnetic resonance imaging (fMRI) is finding widespread appli cation. Unique among brain imaging techniques, fMRI allows noninvasive three-dimensional mapping of the functioning of the entire brain with spatial resolution less than a millimeter and temporal resolution on the scale of seconds. Presently, there are two approaches to fMRI.
One is based on changes in de oxyhemoglobin that occur because of increased regional blood flow in excess of increased oxidative metabolism, known as blood oxygen level-dependent imaging (Bandettini et aI., 1992;  brain activity were highly correlated (r = 0,83), After 30 min utes of picrotoxinin-induced stimulation, glutamate levels de creased but reBF remained elevated, suggesting that additional factors modulate the relationship between neuronal neurotrans mitters and hemodynamics at these later stages, Key Words: Microdialysis-Picrotoxin-Regional cerebral blood f1ow Brain mapping, Kwong et aI., 1992; Ogawa et aI., 1992) . The other is based on using endogenous water as a tracer to directly quantitate changes in regional cerebral blood flow (rCBF) (Detre et aI., 1992; Williams et aI., 1992; Edel man et aI., 1994; Kim, 1995; Silva et aI., 1995) . Both techniques rely on the linkage between increases in re gional brain activity and increases in regional brain blood flow (or oxygenation). Indeed, a major limitation of fMRI-based studies is that changes in hemodynamics are measured rather than direct measures of neural ac tivity, such as electrical activity, intracellular calcium levels, or neurotransmitter release. There has yet to be a direct in vivo comparison of fMRI with a direct measure of neural activation, especially in response to a neuro chemically specific, localized stimulus. To begin to quantitate the relationship between fMRI responses and neurotransmitter release, we turned to microdialysis, a technique that allows highly localized and neurochemi cally specific stimulation of a brain region, as well as sampling and quantitation of specific neurotransmitters (Bito et aI., 1966; Delgado et aI., 1972; Ungerstadt, 1984) . Using a rat microdialysis system specially con structed for use in the MRI environment (Benveniste et aI., 1992), we infused picrotoxinin, a ,),-aminobutyric acid (GABA)-A inhibitor known to induce neural activ-ity, directly into the cerebral cortex of the rat while moni toring both glutamate release and reBF changes around the microdialysis probe tip. We wished to determine whether the spatial and temporal pattern of reBF changes measured by fMRI would correspond to the ap plied picrotoxinin stimulus and also to the level of glu tamate release as a direct neurochemical measure of ac tivation.
METHODS

Microdialysis
All experiments were conducted according to protocols ap proved by the Animal Care and Use Committee of the Univer sity of Pittsburgh. On the day before the fMRI experiment, anesthetized (2% halothane, 50:50 mixture of N20 and O2), orotracheally intubated, and mechanically ventilated male Sprague-Dawley rats (Harlan Sprague Dawley, Indianapolis, IN, U.S.A.; n = 4, 200 to 250 g) were placed in a stereotactic frame (David Kopf, Tujunga, CA, U.S.A.) for placement of an intracerebral guide cannula (CMAJMicrodialysis, Acton, MA, U.S.A.). Because we desired a microdialysis probe orientation perpendicular to our image plane (constrained to coronal-see below), we needed to insert the guide cannula as nearly hori zontal as possible. Mechanical constraints limited us to a guide cannula orientation 10° below horizontal. A 0.5-cm burr hole was placed at coordinates (relative to Bregma) anteroposterior -6.0 mm, mediolateral +5.3 mm. Using the dorsal-ventral movement control we slowly advanced the guide cannula in a posterior to anterior direction 4.1 mm (from the dura at point anteroposterior -6, mediolateral +5.3). We fixed the guide can nula in position with plastic skull screws and dental cement. After the procedure each animal was extubated, awakened, and allowed to recover overnight in an individual cage with ad libitum food and water.
On the day of the experiment, we anesthetized (urethane, 1.1 g/kg, intraperitoneally), intubated, and ventilated (70:30 N20 to O2), each animal before placement of a femoral arterial line for monitoring of blood pressure, heart rate, and Peo2 and for infusion of pancuronium (0.2 mg·kg-1·h-1). After arterial line placement, we positioned each animal in a special holder in corporating a head coil and warm water blanket (controlled by a rectal probe to maintain animal temperature at 3TC). Just before placement in the magnet bore, we removed the inner stylet of the guide cannula and inserted the microdialysis probe slowly by hand. After probe insertion the animal was posi tioned in the magnet and anatomic scout images (see below) were made to locate the probe tip for placement of the imaging plane. Generally, there was a delay of about an hour between insertion of the probe and the start of the rCBF experiment.
Before probe insertion the microdialysis system was pre pared as follows. Two lO-mL syringes (P1astipack, Becton Dickinson, Franklin Lakes, NJ, U.S.A.) were filled, respec tively, with artificial cerebrospinal fluid (ACSF: NaCI 149 mmollL, KCl 3.7 mmollL, MgCl2 0.9 mmol/L, CaCl2 1.2 mmollL, NaH2P04 1.2 mmol/L, pH 7.4, sterile-filtered before use [Pich et aI., 1993] ) or picrotoxinin (Sigma Chemical Co., St. Louis, MO, U.S.A.) (dissolved in 0.5 mL of ethanol and brought to final concentration of 0.5 mmollL in the above ACSF [2.5%, final ethanol concentration]). We attached each syringe by means of a three-way stopcock to a 5-m length of PE-50 tubing extending to a Y-connector (Small Parts, Inc., Miami, FL, U.S.A.) taped to the front of the magnet. After thoroughly flushing both lines, using the stopcock we diverted the picrotoxinin flow to waste (and to prevent backflow). Flow through the ACSF line was allowed to continue at 3 fLUmin. Flow through both syringes was controlled using a single sy ringe pump (Harvard Apparatus, South Natick, MA, U.S.A.). Two x 1-m lengths of FEP tubing (CMA, 1.2 fLUlO-cm length) were attached to the inlet and outlet ports of custom, nonme tallic microdialysis probes (CMAIl1, polycarbonate mem brane, molecular weight cutoff 20,000, 3-mm tip length). We attached the inlet length of FEP tubing to the outlet of the Y-connector. Using this system we could change fluids using the stopcocks without having to enter the magnet room or in terrupting scanning. Because of the dead space and other con siderations, there was approximately 20 minutes' lag between fluid switches and arrival of solution at the probe tip.
Image acquisition and analysis
All experiments were performed in a Bruker AVANCE 4.7 Tesla/40 cm system (Bruker Instruments, Billerica, MA, U.S.A.) equipped with a 12-cm gradient insert and a 7-cm diameter lH imaging coil. The coronal plane at the right pari etal cortex corresponding to the probe tip was positioned at the isocenter of the magnet after pilot multi slice, spin-echo images. The arterial spin labeling MRI technique (Detre et aI., 1992; Williams et aI., 1992) uses arterial water as a tracer by mag netically inverting the water proton spins continuously using adiabatic fast passage (Dixon et aI., 1986) . To measure rCBF two brain images are necessary: a labeled image with the in version plane centered over the carotid arteries and a control image with the inversion plane centered symmetrically oppo site to the original inversion plane. The latter positioning of the inversion plane controls for off-resonance saturation of tissue water owing to cross-relaxation with macromolecules (Zhang et aI., 1992) . Spin-echo rCBF images were acquired with the following parameters: repetition time = 2 seconds, echo time = 6.4 msec, number of averages = 2, field of view = 3.0 cm, and matrix size = 256 x 130. In the first two rats, there was a 9-minute interval per rCBF pairing. Subsequently, a rapid ac quisition with relaxation enhancement factor of two was used to reduce scan times by a corresponding factor. However, to accommodate the full dataset all rCBF data were binned into 9-minute intervals.
All images were motion-corrected using AIR3.0 (Woods et aI., 1992) before analysis. Control and labeled images were collected in an alternating sequence. For every coIUrol-labeled and labeled-control pairing, rCBF was calculated for each pixel using the following equation:
where A is the blood-brain partition coefficient for water, 0.9 mUg (Herscovitch and Raichle, 1985) ; M e is the magnetization intensity of the control image; M L is the magnetization intensity of the labeled image; a is the efficiency of labeling, 0.8 (Zhang et aI., 1993) ; and T 10bs is the in vivo spin-lattice relaxation time for tissue water, 1.6 seconds (Detre et aI., 1992) .
Analysis of rCBF versus distance profile
Because the arterial spin-labeling procedure also labeled fluid flowing through the probe, the probe tip was brightly lit in the baseline rCBF maps. The brightest point was considered the probe tip center. We recorded the rCBF value for each within brain voxel at each time point for each rat. Voxels greater than 3 mm from the probe tip center were excluded from further analysis. Four baseline rCBF maps were discarded owing to a software error. There was at least one good baseline rCBF image from each rat. To determine whether the obtained rCBF profiles were consistent with the known binding properties of picrotoxinin and the diffusive kinetics of microdialysis, we used data from Dykstra et al. (1992) to generate the expected normalized concentration profile around the probe as a function of time. This was converted into an expected picrotoxinin con centration profile by multiplying by the concentration of pic rotoxinin in the dialysate (500 f.1moIlL) and an assumed 20% transfer coefficient for picrotoxinin across the dialysis mem brane. The transfer coefficient estimate is based on the molecu lar weight of picrotoxinin (MW, 292) (Kendrick, 1989) . As suming a simple rectangular hyperbolic relationship between picrotoxinin concentration and rCBF of the form
we estimated the values of maximal rCBF and Kda pp picrotox inin and compared the latter with the known value.
Glutamate analysis
During microdialysis, outflow samples (averaging 20 mini sample) were collected on ice and then frozen in liquid nitrogen and stored at -80°C. Glutamate levels were measured with an amino acid analyzer equipped to detect o-phthalaldehyde derivatized amino acids fluorometrically (Model 6300, Beck man Instruments, Palo Alto, CA, U.S.A.). Aliquots of dialysate were combined with an internal standard, glucosaminic acid and sulfosalicylic acid (Sigma), vortexed, and then centrifuged at 16,OOOg for 10 minutes. Supernatants were filtered using 0.45-f.1m Micro-filterfuge tubes (Rainin Instruments, Woburn, MA, U.S.A.) to remove particulates before injection into the analyzer. Amino acid peaks were identified and integrated us ing an HP3365 Series II Chemstation (Hewlett Packard Corp., Wilmington, DE, U.S.A.). Glutamate concentrations in the samples were calculated correcting for recovery of the internal standard.
RESULTS
Nonmetallic microdialysis probes were stereotacti cally implanted in the parietal cortex of four male Spra gue-Dawley rats. Brain rCBF was measured by fMRI using spin-labeling of arterial water (Detre et aI., 1992; Williams et aI., 1992; Edelman et aI., 1994; Kim, 1995; Silva et aI., 1995) . We performed several temporal se quences of infusion of picrotoxinin. For all infusion pro tocols baseline rCBF maps with ACSF running through the probe were obtained before switching on the picro toxinin. In the first two rats, we infused picrotoxinin for 60 minutes. As shown in Fig. I , a large increase in rCBF was readily detected in a radially symmetric manner around the probe tip. In the third rat, to monitor stability of rCBF response, we infused picrotoxinin for 110 min utes. Finally, in the fourth rat (to test repeatability), we ran an Off-On-Off-On sequence that had picrotoxinin on for 30 minutes, off for 50 minutes, and back on for 60 minutes. These results are shown in 
FIG. 2. Time course of local rCBF follows temporal profile of GABAergic inhibition. Panels
A-E show rCBF around the probe tip at baseline and 27. 54, 90, and 108 minutes after switching to picrotoxinin for rat 3. Panels F-H show baseline and 27 and 54 minutes after first picrotoxinin stimulation in rat 4. Panel I is return to baseline at 90 minutes (60 minutes after stopping initial picrotoxinin stimulation in rat 4). Panel J shows reactivation at 135 minutes (55 minutes after start of second picrotoxinin stimulation in rat 4). The upper right panel for each rat is the mean anatomic image (average of all labeled and unlabeled scans) with an outline corresponding to the location of the rCBF maps shown. White bar in A and F = 1 mm. The grayscale values from black to white represent rCBF of 0; 1.4; 2.2; 2.9; 3.7; 4.5; 5.3; 6.0 mL·g tissue-1·min-'. minutes after arrival of picrotoxinin at the probe tip), increases in rCBF are measurable at least 1.5 mm radi ally from the probe tip. Table 1 presents the derived picrotoxinin concentration versus distance profile (Dyk stra et aI., 1992) and a comparison of the experimentally measured mean rCBF versus distance data and the mean rCBF that was fitted using parameter estimates for maxi mal rCBF (5.5 ± 1.4 mL'g-I 'minl ) and the Kda pp pic rotoxinin (3.5 ± 2.9 j-Lmol/L). There is close agreement between the measured and the fitted mean rCBF data.
The derived Kda pp obtained from the model agrees well with the direct membrane-binding techniques used by Ticku et al. (1978) that measured the Kd for picrotoxinin as 1 to 2 j-LmollL. Figure 4 shows a plot of glutamate concentration in the microdialysate versus the rCBF measured at the cor responding time. The Pearson product-moment correla tion between rCBF and interstitial glutamate concentra tion was 0.83 (n = 12, P < 0.00 1) for time points with 30 minutes or less exposure to picrotoxinin (dark circles in Fig. 4 ). For picrotoxinin exposures longer than 30 minutes there was a correlation of 0.54 (n = 9, P < 0. 14). The slopes of the linear regressions are quite simi1ar' suggesting that the relationship between glutamate release and rCBF is consistent throughout the experi ment, although prolonged picrotoxinin exposure does ap pear to alter the zero glutamate versus rCBF intercept.
DISCUSSION
The present work makes three important contributions. Expected normalized concentrations at each radial distance were derived (Dykstra et aI., 1992) . The expected concentration at each distance was calculated by multiplying [picrotoxinin in dialysate, 500 fLmollLj x normalized concentration x transfer coefficient. Measured rCBF is the average value during first picrotoxinin exposure for all rats (n = 4) shown in Fig. 3 . Inset shows mean (± SE) levels of glutamate release for samples with no (Off), less than 30 minutes (E), and more than 30 minutes (l) of picrotoxinin exposure. Glutamate levels in dialysate are uncorrected for recovery.
distance from the microdialysis probe allows an excel lent estimate of the Kda pp for picrotoxinin binding to receptor. It should be noted that the accuracy of Kd . . a pp estImates lS dependent on the accuracy of the transfer coefficient determination. Because we had no assay for picrotoxinin concentration, we were unable to determine the transfer coefficient directly. The 20% transfer coef ficient used in our calculation was an upper limit esti mate based on published molecular weight versus trans fer coefficient data (Kendrick, 1989) and interpolating to picrotoxinin's molecular weight. We did however di rectly determine the transfer coefficient for glutamate in our microdialysis system (e.g., 16%). Given that gluta mate has a slightly lower molecular weight than picro toxinin, it would be expected to have a slightly larger transfer coefficient. Using a transfer coefficient estimate of 15% leads to a Kda pp estimate for picrotoxinin binding of 2.8 f,LmollL (in even closer agreement to published values). Thus, this procedure may be useful for deter mining Kda pp with other compounds.
We also attempted to use spatial rCBF information to determine whether nitric oxide (NO) production could be involved in the rCBF response in this system (as has been suggested in other work using local application of bicuculline; Pereira de Vasconcelos et aI., 1995). Models of diffusional spread suggest that NO should spread rap idly « 10 seconds) for distances up to 0.5 mm from its source (Wood and Garthwaite, 1994) However, our data for longer exposures, in which high rCBF is maintained in the face of declining glutamate levels, suggests that multiple factors modulate the rela tion between neural excitatory activity and rCBF. We rule out time per se as a factor by noting that after ces sation of picrotoxinin stimulation, rCBF returns to base line regardless of duration of exposure. Possibly the un coupling indicates that the releasable pool of glutamate in local neurons is becoming depleted, the affected glu tamate neurons have become refractory to the pharma cologic stimulus, or later in the picrotoxinin exposure period, the increase in rCBF is being driven by other endogenous stimuli. Some support for the last possibility is provided by the recent observation that picrotoxinin induced seizures can occur in the absence of increased glutamate release (Obrenovitch et aI., 1996) . Future stud ies will hopefully allow us to distinguish among these and other possibilities.
Combining microdialysis with fMRI is a significant advance compared with either autoradiographic tech niques that allow measurement of rCBF at only one time point and require killing the animal, or optical techniques that are limited to the outer 0.5 mm of exposed brain.
Although not used here, multislice or three-dimensional rCBF fMRI at high spatial and temporal resolution can be performed (Silva et aI., 1995) and will enable the global effects of regional stimulation to be examined.
This should allow identification of distributed systems of brain activity through temporal correlations in their pat terns of activity (Friston et aI., 1993 
